Yoshiko Atsuta

135PUBLICATIONS
344CO-AUTHORS
Predictive and prognostic markersHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (135)

|Aug 14, 2026
ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

|Jul 27, 2026
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.

|Jun 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

|Jun 17, 2026
WT1 peptide vaccines of post-allogeneic HSCT maintenance immunotherapy for pediatric acute leukemias: a phase 2 study.

|Jun 11, 2026
Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in Japan.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

Pageof 23

Frequent Collaborators

61 joint publications

Naoyuki Uchida

58 joint publications

Junya Kanda

38 joint publications

Yoshinobu Kanda

37 joint publications

Shuichi Ota